A prospective study to see the effect of fenugreek seed powder ashypoglycemic agent on type ii diabetes mellitus.

Author(s): Rajesh Kumar Shrivastava, Mukseh Meena, Meena Varma, Susmit Kosta, Ravindra Kumar

Abstract

This prospective study was designed to see the hypoglycemic properties of fenugreek seeds on the noninsulin-dependent diabetes mellitus patients. Fenugreek seed powder with a dose of 15mg/day was given to 34 noninsulin-dependent diabetes mellitus patients and 15 healthy controls for 30 days. The blood glucose (FBS and PPBS), Liver function test, lipid profile and Kidney function test were measured after 15th, 30th and 45th day. We observed there was a significant reduction in FBS, PPBS and Hba1C levels after administration of Fenugreek seeds in diabetic patients. However no change was observed in liver functions, lipid profile and kidney functions which show fenugreek seeds have no toxicological effect. Fenugreek seed can be used as hypoglycemic agent in NIDDM patients. However close monitoring of vitals should always been done.

Share this article

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.